ASX Surges on US Tariff Relief: Neuren Soars with FDA Approval, GGE Leads Small Caps Rally
The Australian share market has started the week on a strong note, with the ASX surging on relief from the latest developments in Washington. The market has been boosted by the news of tariff relief, with investors breathing a sigh of relief. Neuren has been a standout performer, rocketing after receiving a green light from the FDA, while GGE has led the charge among small caps. The positive sentiment has been fueled by a strong close on Wall Street, despite concerns over 'Sell America' talk. As the market continues to react to the latest news, investors are keenly watching the developments in the US-China trade tensions. With the ASX trending upwards, investors are advised to keep a close eye on the market, with key stocks like Neuren and GGE expected to continue their upward momentum. The Australian stock market is expected to remain volatile, with trade tensions and economic indicators likely to influence market sentiment. Key terms: ASX, stock market, trade tensions, FDA approval, small caps.